A carregar...
Supportive care treatments for toxicities of anti-egfr and other targeted agents
Targeting of the epidermal growth factor receptor (egfr) pathway has become routine practice in the treatment of lung carcinoma. As more health authorities approve targeted compounds in a variety of treatment lines, use of this approach is expected only to increase. Gefitinib, an oral tyrosine kinas...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Multimed Inc.
2012
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3377756/ https://ncbi.nlm.nih.gov/pubmed/22787412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.19.1054 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|